These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18934526)

  • 21. [Mechanism of prolonged hypocoagulation appearing after intratracheal administration of heparin].
    Efimov VS; Rumiantseva AG; Golovleva OA; Rozkin MIa
    Biull Eksp Biol Med; 1992 May; 113(5):509-12. PubMed ID: 1421273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Coagulation studies and treatment with heparin in a case of hemolytic-uremic-syndrome (author's transl)].
    Ploier R
    Padiatr Padol; 1974; 9(3):276-81. PubMed ID: 4408956
    [No Abstract]   [Full Text] [Related]  

  • 23. [Monitoring heparin therapy].
    Wettendorff P
    Rev Med Brux; 1983 Jan; 4(1):27-31. PubMed ID: 6836204
    [No Abstract]   [Full Text] [Related]  

  • 24. Thrombodynamics, a new global coagulation test: Measurement of heparin efficiency.
    Sinauridze EI; Vuimo TA; Tarandovskiy ID; Ovsepyan RA; Surov SS; Korotina NG; Serebriyskiy II; Lutsenko MM; Sokolov AL; Ataullakhanov FI
    Talanta; 2018 Apr; 180():282-291. PubMed ID: 29332812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-time measurement of free thrombin: evaluation of the usability of a new thrombin assay for coagulation monitoring during extracorporeal circulation.
    Krajewski S; Krauss S; Kurz J; Neumann B; Schlensak C; Wendel HP
    Thromb Res; 2014 Mar; 133(3):455-63. PubMed ID: 24359968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Stability of the anticoagulating effect of calcium and sodium heparin, injected subcutaneously].
    Langer B; Pinto WC; Maia RA; Kwang WT; Leão LE
    AMB Rev Assoc Med Bras; 1978 Apr; 24(4):121-3. PubMed ID: 308244
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of aureomycin on heparin concentration and clotting time of human blood.
    WAISBREN BA; GLICK D
    J Lab Clin Med; 1950 Dec; 36(6):1001. PubMed ID: 14795098
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determination of heparin in blood plasma].
    Kotovshchikova MA; Krasko SS
    Lab Delo; 1974; 8(0):460-3. PubMed ID: 4139363
    [No Abstract]   [Full Text] [Related]  

  • 29. The intensity and duration of the effect of depo-heparin on venous coagulation time in man.
    MOSS H; D'ALESSANDRO DR
    Am Pract Dig Treat; 1951 Apr; 2(4):309-10. PubMed ID: 14819525
    [No Abstract]   [Full Text] [Related]  

  • 30. Interaction studies with metolazone, heparin and protamine sulfate.
    Yelnosky J; Borrelli A; Kaiser F; Belair E
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):5-11. PubMed ID: 4746632
    [No Abstract]   [Full Text] [Related]  

  • 31. Action of modified heparins on coagulation: in vitro and in vivo studies.
    Stemberger AW; Riedl A; Haas S; Breddin HK; Walenga JM; Blümel G
    Semin Thromb Hemost; 1991; 17 Suppl 1():80-4. PubMed ID: 1648792
    [No Abstract]   [Full Text] [Related]  

  • 32. [Problems of blood coagulation. V. Effect of heparin-like anticoagulants on the first phase of blood coagulation].
    MARBET R; WINTERSTEIN A
    Helv Physiol Pharmacol Acta; 1952; 10(4):528-42. PubMed ID: 13044146
    [No Abstract]   [Full Text] [Related]  

  • 33. [EFFECT OF SURGERY ON BLOOD COAGULATION].
    ZYKAS V
    Sveikatos Apsauga; 1963 Dec; 8():8-13. PubMed ID: 14111268
    [No Abstract]   [Full Text] [Related]  

  • 34. [On various aspects of blood coagulation in obesity. II. Studies on the aggregation ("clumping") of thrombocytes "in vitro" and on the thromboplastin formation].
    Gavrilescu S; Bartl F; Csernik I; Anghelescu L; Moga D
    Dtsch Z Verdau Stoffwechselkr; 1967 Dec; 27(5):191-5. PubMed ID: 5595739
    [No Abstract]   [Full Text] [Related]  

  • 35. Fat infusions and blood coagulation. Effect of various fat emulsions on blood coagulability. A comparative study.
    Brockner J; Amris CJ; Larsen V
    Acta Chir Scand Suppl; 1965; 343():48-55. PubMed ID: 5214023
    [No Abstract]   [Full Text] [Related]  

  • 36. [Thrombolytic properties of the heparin-tissue plasminogen activator complex and its effect on the fibrinolytic and coagulating systems of the blood in animals].
    Shimonaeva EE; Andreenko GV
    Vopr Med Khim; 1988; 34(1):59-62. PubMed ID: 3130724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Behavior of coagulation time of blood in normal and pathological subjects following intravenous administration of heparin (De Takats test)].
    DOTTI F; BONORA G
    Rass Int Clin Ter; 1950 Jun; 30(12):364-5. PubMed ID: 14781388
    [No Abstract]   [Full Text] [Related]  

  • 38. [Complexes of heparin with nicotinic acid and nicotinamide and their physiological properties].
    Kudriashov BA; Liapina LA; Kondashevskaia MV
    Dokl Akad Nauk SSSR; 1986; 291(1):242-5. PubMed ID: 2947789
    [No Abstract]   [Full Text] [Related]  

  • 39. The relation between heparin blood levels and blood coagulation times.
    MONKHOUSE FC; MACMILLAN RL; BROWN KW
    J Lab Clin Med; 1953 Jul; 42(1):92-7. PubMed ID: 13061833
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies on the fibrinolytic action of heparin substance in man].
    De Nicola P; Gibelli A; Turazza G; Nadile L
    Arzneimittelforschung; 1965 Dec; 15(12):1430-3. PubMed ID: 4225447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.